HCAR2 and malignant colon neoplasm: Activation of GPR109A by the bacterial fermentation product, butyrate, has been shown to exert tumour-suppressing effects in colon cancer [47]; while in cerebral hypoxia, β-hydroxybutyrate is shown to be neuroprotective [48]–[50].